Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Transition to 37°C reveals importance of NADPH in mitigating oxidative stress in stored RBCs
Aline Roch, Nicholas J. Magon, Jessica Maire, Cacang Suarna, Anita Ayer, Sophie Waldvogel, Beat A. Imhof, Mark J. Koury, Roland Stocker, Marc Schapira
Aline Roch, Nicholas J. Magon, Jessica Maire, Cacang Suarna, Anita Ayer, Sophie Waldvogel, Beat A. Imhof, Mark J. Koury, Roland Stocker, Marc Schapira
View: Text | PDF
Research Article Hematology Metabolism

Transition to 37°C reveals importance of NADPH in mitigating oxidative stress in stored RBCs

  • Text
  • PDF
Abstract

The RBC storage lesion is a multiparametric response that occurs during storage at 4°C, but its impact on transfused patients remains unclear. In studies of the RBC storage lesion, the temperature transition from cold storage to normal body temperature that occurs during transfusion has received limited attention. We hypothesized that multiple deleterious events might occur in this period of increasing temperature. We show dramatic alterations in several properties of therapeutic blood units stored at 4°C after warming them to normal body temperature (37°C), as well as febrile temperature (40°C). In particular, the intracellular content and redox state of NADP(H) were directly affected by post-storage incubation at 37°C, as well as by pro-oxidant storage conditions. Modulation of the NADPH-producing pentose phosphate pathway, but not the prevention of hemoglobin autoxidation by conversion of oxyhemoglobin to carboxyhemoglobin, provided protection against storage-induced alterations in RBCs, demonstrating the central role of NADPH in mitigating increased susceptibility of stored RBCs to oxidative stress. We propose that assessing RBC oxidative status after restoration of body temperature constitutes a sensitive method for detecting storage-related alterations that has the potential to improve the quality of stored RBCs for transfusion.

Authors

Aline Roch, Nicholas J. Magon, Jessica Maire, Cacang Suarna, Anita Ayer, Sophie Waldvogel, Beat A. Imhof, Mark J. Koury, Roland Stocker, Marc Schapira

×

Figure 5

Effects of PIPA on physical properties, Prx2 dimerization, and NADPH content of RBCs stored at 4°C prior to challenge with copper/ascorbate treatment or warming to 37°C.

Options: View larger image (or click on image) Download as PowerPoint
Effects of PIPA on physical properties, Prx2 dimerization, and NADPH con...
(A) Osmotic fragility based on solution osmolality leading to 50% hemolysis (n = 3); and (B) percent lysed erythrocytes (n = 3) in untreated RBC samples (circles) or samples treated (triangles) with 15% PIPA solution (sodium phosphate, inosine, sodium pyruvate, and adenine), followed by copper/ascorbate treatment for 0 (Control), 4, 24, or 48 hours at 4°C. (C–E) Osmotic fragility based on solution osmolality leading to 50% hemolysis in untreated RBC samples (white), samples treated with 15% PIPA solution on day 0 (light gray), (C) samples treated during 1 hour with 15% PIPA solution after storage (dark gray) (n = 3), (D) samples treated with 30% PIPA solution on day 0 (dark gray) (n = 6), or (E) samples treated with 15% PIPA solution at week 0 and week 3 (dark gray) (n = 6), and stored at 4°C for 0, 2, 4, or 6 weeks. (F) Percent lysed erythrocytes (n = 6) in untreated RBC samples (white) or samples treated with 15% PIPA solution on day 0 (gray) and stored at 4°C for 0, 2, 4, or 6 weeks. (G) Total NADP(H) and (H) NADPH determined by enzymatic cycling in untreated RBC samples (white) or samples treated with 15% (light gray) or 30% (dark gray) PIPA solution on day 0 and stored at 4°C for 0, 2, 4, or 6 weeks, followed by 20 hours at 37°C (n = 6). Box plots show median, 25th and 75th percentiles (box), and minimum/maximum values (whiskers). Bars show mean values. *P ≤ 0.05, repeated-measures 2-way ANOVA; #P ≤ 0.05, Mann-Whitney nonparametric test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts